In patients with pancreatic cancer, the mean value of glutathione reductase and glutathione s-transferase enzymes decreased, while the mean value of prolidase, and adenosine deaminase, enzyme activities increased (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:The purpose of this study is to determine the relationship between enzymatic antioxidants such as glutathione reductase and glutathione s-transferase and prolidase and adenosine deaminase in patients diagnosed with pancreatic cancer.
📊
Temel Bulgular & Veri:Prolidase, adenosine deaminase, glutathione s-transferase and glutathione reductase activities were determined spectrophotometrically in blood sera collected from patients and healthy control subjects included in the study.
💡
Sonuç & Katkı:In patients with pancreatic cancer, the mean value of glutathione reductase and glutathione s-transferase enzymes decreased, while the mean value of prolidase, and adenosine deaminase, enzyme activities increased (p
The purpose of this study is to determine the relationship between enzymatic antioxidants such as glutathione reductase and glutathione s-transferase and prolidase and adenosine deaminase in patients diagnosed with pancreatic cancer. Prolidase, adenosine deaminase, glutathione s-transferase and glutathione reductase activities were determined spectrophotometrically in blood sera collected from patients and healthy control subjects included in the study. In patients with pancreatic cancer, the mean value of glutathione reductase and glutathione s-transferase enzymes decreased, while the mean value of prolidase, and adenosine deaminase, enzyme activities increased (p
Demir, C., Kanmaz, H., Ermaya, M., Demir, H. (2022). INVESTİGATION OF AVERAGE VALUES OF PROLIDASE, ADENOZIN DEAMINASE, GLUTATHIONE S-TRANSFERASE AND GLUTATHIONE REDUCTASE ENZYMES IN PANCREAS CANCERS. Clinical and Experimental Health Sciences, Cilt: 11 - Sayı: 3, 542–546. https://ajindex.com/articles/474168
Mills S.E. Sternberg's Diagnostic surgical pathology. Lippincott Williams & Wilkins. 2010: Cilt 2, Philadelphia s: 1442-43
Abeloff MD, Armitage JO, Niederhuber J.E. Carcinoma of the Pancreas. Clinical Oncology. 2008;4 thed. Philadelphia p. 1596
Wilkowski R, Boeck S, Ostermaier S. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine- cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study. British Journal of Cancer.2009; 101: 1853-59
Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin. 2008;58(2): 71 -96. 5.Bell E.T. Carcinoma of the pancreas, 1.A clinical and pathologic study of 609 necropsied cases, 11. The relation of carcinoma of the pancreas to diabetes mellitus.1957; Am. J. Pathol. 33: 499
Nakase A, Watsumoto Y., Uchida K.Surgical treatment of cancer of the pancreas and the periampullary region; cumulative results in 5 7 institutions in Japan. Ann. Surg. 1977;185: 52
Greer JB, Yazer M, Raval J. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol.2010; 16(44): 5588-91
Hart AR. Pancreatic cancer: any prospects for prevention?. Postgraduate Medical Journal. 1999;75(887):521-26). 10.Zanaboni G, Dyne K.M, Rossi A, et al. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica.1994;79:13-18. 11.Palka J.A, Phang J.M. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors, J Cell Biochem., 1997;67: 166-175
McRae P.A, Porter B.E. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem Int. 2012;61:963-972
Lizuka H, Kouzumi H, Kamigaki K, Aoyagi T, Miura Y. Two forms of adenosine deaminase in pig epidermis. J.Dermatol. 1981; 8: 91-95